Renal Failure 2010-01-01

Orlistat and calcium oxalate crystalluria: an association that needs consideration.

Mohamed H Ahmed

文献索引：Ren. Fail. 32(8) , 1019-21, (2010)

全文：HTML全文

摘要

Obesity is currently an epidemic across the globe. Obese patients unable to achieve significant weight loss with lifestyle changes alone may require drug therapy. Clinical trials have shown that orlistat administration may not only lead to weight loss but also protect against type 2 diabetes in around 37% of cases. Orlistat can induce and maintain weight loss, even in patients with comorbid conditions such as hypertension or type 2 diabetes. Recently, orlistat can induce marked weight loss in individuals with chronic kidney disease (CKD). In small numbers of individuals especially those with CKD, orlistat administration may precipitate oxalate nephropathy and renal stone disease. The focus of this article is to review current studies showing impact of orlistat on renal function and outcomes.

相关化合物

  • 草酸钙
  • 奥利司他

相关文献：

Isolation and characterization of oxalotrophic bacteria from tropical soils.

2015-01-01

[Arch. Microbiol. 197(1) , 65-77, (2015)]

In vivo synthesis of calcium oxalate whiskers on CoCrMo alloy surfaces via biomineralization.

2013-10-01

[Mater. Sci. Eng. C. Mater. Biol. Appl. 33(7) , 3839-44, (2013)]

In vitro calcium oxalate crystallisation methods.

2006-04-01

[Urol. Res. 34(2) , 139-45, (2006)]

The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease.

2013-06-01

[Urolithiasis 41(3) , 187-96, (2013)]

Bilateral very large calcium oxalate stones in the seminal vesicles: case report and literature review.

2011-12-01

[Urol. Res. 39(6) , 509-13, (2011)]

更多文献...